Chair of Chemical Safety Board to Step Down

Vanessa Allen Sutherland will resign next month, leaving the agency with just three members of what should be a five-person board.

Written byAshley Yeager
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, DSZCVanessa Allen Sutherland will resign next month as chair of the US Chemical Safety & Hazard Investigation Board. With the vacancy, the board will drop to having only three members—two short of the standard five, C&EN reported earlier this week (May 22).

“The remaining board members will be required to vote on an interim executive, unless and until the White House nominates and the Senate confirms a new Chairperson,” the board, usually referred to as the Chemical Safety Board (CSB), says in a statement. However, that nomination is in doubt, C&EN notes, as the Trump administration has twice tried to shut down the CSB altogether.

Sutherland did not give a reason for stepping down. “I am saddened to leave the wonderful mission and incredible work of the CSB. This mission is unique and critically important because we are the only agency conducting independent, comprehensive root cause chemical incident investigations,” she says in the statement.

Before Sutherland signed on in 2015, CSB had a shaky history. Congress and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies